Courtesy of Mary E. Hall
Editor s note: This story has been updated to reflect that the event is no longer a fundraising opportunity.
HILLTOWN U.S. District Court Judge Cynthia M. Rufe has been named 2021 “Woman of Influence,” an accolade to be presented by Pearl S. Buck International at a dinner and awards ceremony June 24 on the grounds of the Pearl S. Buck House, 520 Dublin Road.
Rufe, a Bucks County native who serves as a judge of the U.S. District Court for the Eastern District of Pennsylvania, will be the guest of honor at a dinner and award presentation from 6 to 8 p.m. Guests attending the event will be required to follow COVID-19 health and safety protocols, including social distancing and mask-wearing.
ADVERTISEMENT
ADVERTISEMENT
AGs Warn Against Sanctioning Calif. In Generics Pricing MDL
Law360 (April 27, 2021, 5:39 PM EDT) The attorneys general of Pennsylvania, Oregon and Minnesota urged a Pennsylvania federal judge to reject a special master s recommendation to sanction the California Attorney General s Office for failing to fulfill discovery obligations in multidistrict litigation over inflated medication prices, arguing that it has broad implications.
The state attorneys general argued in an eight-page filing Monday to U.S. District Judge Cynthia M. Rufe that even though the proposed sanctions of barring certain evidence are directed solely at California, the scope of the penalties would hurt the state enforcers and potentially other plaintiffs if applied more broadly. The state attorneys general are among dozens of.
ADVERTISEMENT
ADVERTISEMENT
States Push New Bellwether Generic Drug Price-Fixing Case
Law360 (March 17, 2021, 5:42 PM EDT) If a Pennsylvania federal judge wants to swap out the bellwether case in sprawling litigation that accuses much of the generic drug industry of price-fixing, a coalition of attorneys general want her to choose a different state-brought case than the one she s currently considering as a replacement.
Right now U.S. District Judge Cynthia M. Rufe has two main options for a bellwether after she decided the current selection a state enforcer case that focuses mainly on Teva Pharmaceuticals wasn t a good candidate due to pending criminal charges.
ADVERTISEMENT
ADVERTISEMENT
Teva, Mylan Back Plan For New Bellwether In Price-Fix MDL
Law360 (March 2, 2021, 6:53 PM EST) Mylan, Teva and Par Pharmaceuticals are among a group of generic-drug makers that told a Pennsylvania federal judge Monday they re fine with her plan to swap out a bellwether case in multidistrict litigation that accuses most of the generics industry of price-fixing.
The companies told U.S. District Judge Cynthia M. Rufe they share her inclination for scrapping the planned bellwether trial in a case brought by various state attorneys general that centers around Teva. Instead, the companies want Judge Rufe to select another case one that focuses on Heritage Pharmaceuticals, which the court mentioned as a possibility less than a.
Parties in Teva generic drug antitrust MDL given go-ahead to argue selection of bellwether cases pennrecord.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pennrecord.com Daily Mail and Mail on Sunday newspapers.